TF-1
Export
premyeloid cell line from patient with erythroleukemia
Cell Type:
Erythroblast
Tissue Origin:
bone marrow
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
T
T-001
2e6
38%
82% ±3
Plasmid (general)
2 µg
100 µl
I/II/2b
SF
FF-100
4e5
43-63%
48-68%
Plasmid (general)
0.4 µg
20 µl
4D X-Unit
SF
FF-100
2e6
54-68%
49-63%
Plasmid (general)
2 µg
100 µl
4D X-Unit
Citations
PMA-Induced Differentiation of a Bone Marrow Progenitor Cell Line Activates HIV-1 LTR-Driven Transcription
Categories:
Transfection
Authors:
Alexaki A, Quiterio SJ, Liu Y, Irish B, Kilareski E, Nonnemacher MR, Wigdahl B
In:
DNA Cell Biol (2007) 26(6): 387-94
JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization
Categories:
Transfection
Authors:
Martinez-Moczygemba M, Huston DP, Lei JT
In:
J Leukoc Biol (2007) 81(4): 1137-48
NALP1 is a transcriptional target for cAMP-response-element-binding protein (CREB) in myeloid leukaemia cells
Categories:
Transfection
Authors:
Sanz C, Calasanz MJ, Andreu E, Richard C, Prosper F, Fernandez-Luna JL
In:
Biochem J (2004) 384(Pt 2): 281-6